Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Eton Pharmaceuticals (ETON) Debt Ratio (2020 - 2025)

Eton Pharmaceuticals' Debt Ratio history spans 6 years, with the latest figure at 0.29 for Q3 2025.

  • For Q3 2025, Debt Ratio rose 152.46% year-over-year to 0.29; the TTM value through Sep 2025 reached 0.29, up 152.46%, while the annual FY2024 figure was 0.39, 131.04% up from the prior year.
  • Debt Ratio for Q3 2025 was 0.29 at Eton Pharmaceuticals, down from 0.3 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.39 in Q4 2024 and bottomed at 0.01 in Q1 2021.
  • The 5-year median for Debt Ratio is 0.05 (2021), against an average of 0.11.
  • The largest annual shift saw Debt Ratio surged 385.3% in 2021 before it plummeted 36.94% in 2022.
  • A 5-year view of Debt Ratio shows it stood at 0.05 in 2021, then fell by 20.06% to 0.04 in 2022, then soared by 310.71% to 0.17 in 2023, then surged by 131.04% to 0.39 in 2024, then decreased by 25.8% to 0.29 in 2025.
  • Per Business Quant, the three most recent readings for ETON's Debt Ratio are 0.29 (Q3 2025), 0.3 (Q2 2025), and 0.39 (Q4 2024).